You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 21, 2024

Ciclopirox - Generic Drug Details


✉ Email this page to a colleague

« Back to Dashboard


What are the generic drug sources for ciclopirox and what is the scope of patent protection?

Ciclopirox is the generic ingredient in three branded drugs marketed by Cosette, Fougera Pharms, Glenmark Pharms, Padagis Israel, Taro, Medimetriks Pharms, Alvogen, Glenmark Pharms Inc, Padagis Us, Actavis Mid Atlantic, Encube, Bausch, Acella, Chartwell Rx, Epic Pharma Llc, Hikma, Mylan Pharms Inc, Rising, Taro Pharm Inds, Teva Pharms, and Valeant Bermuda, and is included in thirty-two NDAs. Additional information is available in the individual branded drug profile pages.

There are ten drug master file entries for ciclopirox. Sixteen suppliers are listed for this compound.

Drug Prices for ciclopirox

See drug prices for ciclopirox

Drug Sales Revenue Trends for ciclopirox

See drug sales revenues for ciclopirox

Recent Clinical Trials for ciclopirox

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
Universidad Complutense de MadridPhase 4
Atlas Molecular PharmaPhase 1
BCDiabetes.CaN/A

See all ciclopirox clinical trials

Pharmacology for ciclopirox
Paragraph IV (Patent) Challenges for CICLOPIROX
Tradename Dosage Ingredient Strength NDA ANDAs Submitted Submissiondate
CICLOPIROX Gel ciclopirox 0.77% 020519 1 2006-05-10

US Patents and Regulatory Information for ciclopirox

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Padagis Us CICLOPIROX ciclopirox GEL;TOPICAL 078266-001 Jan 7, 2009 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Glenmark Pharms Inc CICLOPIROX ciclopirox GEL;TOPICAL 091595-001 Feb 29, 2012 AB RX No Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Medimetriks Pharms LOPROX ciclopirox CREAM;TOPICAL 018748-001 Dec 30, 1982 AB RX Yes Yes ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms CICLOPIROX ciclopirox GEL;TOPICAL 077896-001 Jun 10, 2008 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
Fougera Pharms CICLOPIROX ciclopirox CREAM;TOPICAL 076435-001 Dec 29, 2004 AB RX No No ⤷  Sign Up ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for ciclopirox

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Medimetriks Pharms LOPROX ciclopirox CREAM;TOPICAL 018748-001 Dec 30, 1982 ⤷  Sign Up ⤷  Sign Up
Bausch LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 ⤷  Sign Up ⤷  Sign Up
Bausch LOPROX ciclopirox SHAMPOO;TOPICAL 021159-001 Feb 28, 2003 ⤷  Sign Up ⤷  Sign Up
Medimetriks Pharms LOPROX ciclopirox SUSPENSION;TOPICAL 019824-001 Dec 30, 1988 ⤷  Sign Up ⤷  Sign Up
Valeant Bermuda PENLAC ciclopirox SOLUTION;TOPICAL 021022-001 Dec 17, 1999 ⤷  Sign Up ⤷  Sign Up
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.